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ABSTRACT
Purpose. The purpose of this study was to examine the effects of chronic L-carnitine and
carbohydrate supplementation on body composition, perceived exertion, and athletic
performance in recreationally-trained female endurance runners. Methods. On three separate
occasions, twenty-one days a part, seven recreationally-trained female endurance runners
performed a timed progressive treadmill test to exhaustion as well as a body composition
assessment using the Bod Pod. Participants were randomly assigned to one of two groups – Lcarnitine (LC) or L-carnitine plus carbohydrates (LC + CHO). The LC group consumed 2 g of Lcarnitine L-tartrate and the LC + CHO group consumed 2 g of L-carnitine L-tartrate with 10 g of
flavorless dextrose powder. Rating of perceived exertion, time to fatigue, and body composition
was recorded during each of the three visits. Results. The results of this study revealed no
significant interactions or main effects for time and treatment (p = .11). In addition, no
significant differences were seen between subjects for body composition (%FFM p = .54; FFM p
= .17; FM p = .75; %FM p = .57) or RPE (p = .95). Conclusion. In conclusion, this study
demonstrated that chronic carnitine and carbohydrate feeding likely does not influence RPE,
time to fatigue, or body composition in recreational endurance-trained female runners.
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CHAPTER 1
INTRODUCTION
Carnitine, a nonprotein amino acid, is found naturally in the body, mainly in the muscles,
and is synthesized from the amino acids lysine and methionine (Orer & Guzel, 2014). Not only is
it found naturally in the body, but L-Carnitine (LC) can be found in numerous dietary food
sources including red meats and dairy, and in smaller amounts in fish, poultry, asparagus,
tempeh, and peanut butter. Carnitine can also be found as a supplement in various forms,
including Acetyl L-Carnitine, Propionyl-L-Carnitine, and the most widely available, L-Carnitine
(Carnitine Shuttle; Ehrlich, 2014). Carnitine is necessary for the important role of shuttling fatty
acids, specifically long-chain fatty acids, across the inner mitochondrial membrane for betaoxidation (Karahan, Coksevim & Artis, 2010). This transport system is the critical rate-limiting
step for beta-oxidation. Thus, if this transport system is continuously in motion, beta-oxidation
will occur at a normal rate, allowing the fatty acid molecules to be broken down in the
mitochondria to generate acetyl-CoA, and eventually ATP.
Carnitine supplementation has become increasingly popular over the years, claiming to
promote fat loss, increase energy, and help prevent an increase in body fat mass. However, the
benefit of carnitine supplementation in individuals without deficiency is widely up for debate
(Watcher et al., 2002). Until recently, few researchers have found significant evidence that
substantiates carnitine feeding to enhance athletic performance. Nevertheless, research now
supports evidence that carnitine supplementation, in combination with carbohydrates (CHO), can
produce ergogenic effects in individuals without deficiency (Broad et al., 2011; Stephens et al.,
2013; Wall et al., 2011).
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As previously mentioned, one of the major claims associated with L-carnitine
supplementation is its potential “fat burning” capability, however, research associated with
carnitine supplementation and fat loss is limited and some studies do not support the use the LC
for fat loss purposes. For instance, Kruszewski (2011) examined changes in maximal strength
and body composition after the ingestion of creatine, L-carnitine, or β-hydroxy-β-methylbutyrate
(HMB) among novice male body builders with little to no training experience. Participants in the
carnitine group consumed either an L-carnitine supplement or placebo, both at 900 mg per day
for a total of 1.2 months. Over that time period, participants were instructed to perform circuit
training-like exercise three times a week at the same time each day. Bioelectrical impedance
analysis (BIA) was then used to determine fat and water content in the body. Results showed no
significant changes in fat or water content in the LC group, as well as no significant changes in
body mass. These findings do not support the claims currently made by supplement companies,
in that carnitine supplementation did not have a significant effect on body composition in these
subjects.
Similarly, Wutzke and Lornez (2004) examined the effect of L-carnitine on fat oxidation,
protein turnover, and body composition in twelve slightly overweight participants (7 females, 5
males; age 18 to 30 years). Participants in the study had kept their weight stable for at least one
month prior to the start of the study. For twenty days, participants were provided with a regular,
individualized diet either with or without 3 g of carnitine per day (10 days with LC, 10 days
without). In order to assess protein turnover, an algae lipid mixture was given to participants
simultaneously on the ninth day. Urine samples were collected at different intervals over a period
of 36 hours after administration of the mixture. In addition, BIA was used to determine body fat
mass (BFM), total body water (TBW), lean body mass (LBM), and body weight (BW). In this
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population, results showed no change in BFM (21.3  4.8 vs 21.5  5.1 kg), LBM (58.1  10.8
vs 58.3  10.6 kg) TBW (42.5  7.9 vs 42.7  7.8 L), and BW (79.4  10.5 vs 79.7  11.5 kg) at
the end of the supplementation period. Once more, few studies have been able to support the use
of carnitine supplementation in preventing body fat accumulation, therefore more research is
necessary to substantiate this claim.
Other interests in carnitine spur from the claim that supplementation has the potential to
improve athletic performance due to carnitine’s role in energy metabolism. Through the carnitine
transport system, fatty acids are able to enter the mitochondria to be broken down for subsequent
-oxidation, specifically during endurance exercise, where the reliance of fatty acids as a fuel
source becomes higher. Watcher, Vogt, & Kreis (2002) investigated the effects of long-term Lcarnitine supplementation on skeletal muscle carnitine content and physical performance in eight
healthy male adults. Using a cycle ergometer, participants exercised for 10 minutes at 20%, 40%,
and 60% of their individual maximal workload (Pmax) until exhaustion. Afterwards, participants
were instructed to consume 2 g of LC two times per day for 3 months. Exercise tests and muscle
biopsies were performed before, immediately after, and two months after the treatment. Results
of the study revealed no significant changes in VO2, RER, blood lactate concentrations, or heart
rate when compared to pretreatment values after 3 months of LC supplementation. In addition, a
5% increase was seen in VO2 at submaximal workloads (40% and 60% of Pmax) when compared
to pretreatment values, however, VO2max, HR, VO2 at 20% Pmax, RER, and blood lactate
concentrations were not significantly different from values obtained before the treatment.
Furthermore, recent research has reported that ingestion of L-carnitine in combination
with carbohydrates has been shown to prolong exercise endurance as well as aid in the recovery
of muscles post-exercise. Wall, Stephens, & Constantin-Teodosiu (2011) examined muscle
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carnitine content and alterations in muscle fuel metabolism during exercise in fourteen
moderately trained athletes. On three separate occasions, participants reported to the lab to
complete a 60-minute cycling test for 30 minutes at 50%, followed immediately by 30 minutes at
80% of their predetermined VO2max. Rating of perceived exertion (RPE) was recorded every ten
minutes. After the first visit, participants were separated into either a control (80 g orangeflavored CHO polymer) or carnitine group (80 g orange-flavored CHO polymer plus 1.36 g of
LC). Blood samples and muscle biopsies were taken on each visit to examine plasma total
carnitine (TC) concentration and muscle free carnitine, acetylcarnitine, and long-chain
acylcarnitine. After 24 weeks of supplementation, results of the study revealed higher plasma TC
concentrations after 12 and 24 weeks in the carnitine group when compared with control, and a
35% decrease in muscle glycogen content after exercise at 50% VO2max. In addition, after
exercise of 80% VO2max, a 44% decrease was seen in muscle lactate content in the carnitine
group compared to control. Work output also increased by 11% from baseline after 24 weeks,
35% greater compared to control. These findings are the first to show that carnitine
concentrations in the muscle can be increased through dietary means and may be exerciseintensity dependent. Wall and colleagues (2011) also demonstrated that at lower intensities (50%
VO2max), increasing muscle carnitine content spares muscle glycogen, thus utilizing lipids as a
fuel source.
Various limitations and inconsistencies exist in current literature involving carnitine
supplementation. Research involving carnitine supplementation has produced conflicting results,
probably due to small sample sizes, inconsistent duration of supplementation, and the use of
mainly male participants. For example, Broad et al. (2011) examined L-Carnitine L-Tartrate
(LCLT) supplementation on sixteen endurance-trained male athletes over a 15-day period and
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found significant differences in mean exercise heart rate (HR) and rating of perceived exertion
when participants performed an exercise test on a cycle ergometer at varying intensities.
Similarly, Mustafa, Beker, & Artis (2010) found that ten days of carnitine supplementation in
twenty male, well-trained athletes produced significant changes in 1500m running performance
time and plasma lactate levels in their control group (fruit juice) compared with the carnitine
group (2 g/day LCLT mixed with fruit juice). In addition, Swart, Rossouw, & Loots (1997)
found significant differences in running speed (5.68% increase from baseline), heart rate, and
respiratory exchange ratio when examining the effect of L-carnitine supplementation on plasma
carnitine levels and different performance parameters in seven male marathon athletes over a
period of six weeks. Participants performed two progressive treadmill tests to exhaustion, and
results of the study showed a 5.68% increase in running speed, as well as a decrease in oxygen
consumption and heart rate when compared to baseline.
In addition to inconsistent sample size and length of supplementation, most studies use
predominantly male or mixed gender samples, whereas few studies have used exclusively female
samples. Within the last few decades, important differences in exercise capacity between males
and females has been brought to light (Sheel, Richards, Foster, & Guenette, 2004). For instance,
compared to males, females tend to utilize more lipid and less carbohydrate for energy during
endurance exercise. In addition, fatigability of skeletal muscle appears to be different when
comparing genders, which could be related to differences in muscle mass, substrate utilization,
and recovery (Sheel, Richards, Foster, & Guenette, 2004). Howden, Perhonen, & Peshock (2015)
examined the effect of cardiovascular response to one year of intensive endurance training on
previously untrained males and females, matched for training volume and intensity. Each
participant underwent various tests every three months to assess body composition as well as
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VO2max, left ventricle mass (LV), and cardiac magnetic resonance imaging (MRI) testing. Results
of the study found that compared to males, female participants had a lower percentage of fat free
mass (FFM) and lower hematocrit levels before training. However, upon completion of the study
protocol, there were no significant differences between sexes for hematocrit, body fat, and
indexed blood volume. Furthermore, VO2max was increased in both sexes (22% in males, 15% in
females), but VO2max response was blunted after three months in female participants compared to
males. In the female population, VO2max, LV mass, and mean wall thickness plateaued after 3
months of training, whereas those same measures increased in male participants before
plateauing in months 9-12. As mentioned in the study, one reason for the plateau in exercise
performance in the female population may be related to the groups suboptimal energy intake, as
the study protocol only provided general dietary advice (Howden, Perhonen, & Peshock, 2015).
This study is one example of the different physiological responses to exercise between males and
females. Other factors that may have contributed to the lack of training effect in exercise
performance include hormonal and environmental factors (Howden, Perhonen, & Peshock,
2015).
Likewise, an important factor to consider when working with the female population and
exercise is the use of oral contraceptives. Joyce, Sabapathy, Bulmer, & Minahan (2013)
examined the effect of long-term oral contraceptive use on the endurance performance of
recreationally active women. Plasma ethanol estradiol, a hormone found in many oral
contraceptives, inhibits the production of the hormone 17 B-estradiol, and appears six times
higher in individuals taking oral contraceptives than those that do not. For this study, participants
were separated into two groups: oral contraceptive (OC) and those who were not using oral
contraceptives (CON). Baseline samples were then taken to assess levels of 17 B-estradiol and
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progesterone. VO2peak and anaerobic threshold (AT) were measured using a cycle ergometer
where participants completed various exercise tests to exhaustion. Heart rate (HR), RPE,
pulmonary gas exchange, blood lactate concentration (La) and time to exhaustion were assessed
during the tests. Significant differences were observed in VO2peak and VO2 at AT in the CON
group when compared to the OC group. However, HR, BP, and La concentrations were not
significantly different between the groups. Results of this study propose that long-term use of
oral contraceptives negatively affect VO2peak and VO2 at AT, but have no effect on athletic
performance in recreationally trained female endurance runners.
Overall, the importance of the current study lies in the fact that few researchers have been
able to produce consistent results with LC supplementation and studies involving carnitine and
CHO supplementation are relatively novel. The current study set out to examine the effect of
chronic L-carnitine and carbohydrate feeding on overall on body composition and athletic
performance in female recreational endurance runners. Chronic carnitine and CHO
supplementation (> 4 weeks) has given promising insight into changes in fuel metabolism and
recovery after exercise. It was hypothesized that participants receiving the CHO + LC would
have a significantly higher work output and would have lower feelings of fatigue when compared
to LC group. In addition, it was hypothesized that participants receiving the CHO + carnitine
supplement will see no increase in fat mass when compared to LC group.
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Purpose Statement:
The purpose of this study was to examine the effects of chronic L-carnitine and carbohydrate
supplementation on body composition, perceived exertion, and athletic performance in female
endurance athletes.
Hypotheses:
1. Subjects receiving the CHO + carnitine supplement will have a significantly higher work
output when compared to the LC group.
2. Subjects receiving the CHO + carnitine supplement will have lower feelings of fatigue
when compared to LC group.
3. Subjects receiving the CHO + carnitine supplement will see no increase in fat mass when
compared to LC group.
Research Questions:
1. Does chronic carnitine and CHO feeding increase work output?
2. Does chronic carnitine and CHO feeding reduce the feeling of fatigue?
3. Does chronic carnitine and CHO feeding prevent increases in body fat mass?
Rationale:
Previous research has produced conflicting results when it comes to L-carnitine (LC)
supplementation and its effect on athletic performance. The importance of this study lies in the
fact that few researchers have been able to produce consistent results with LC supplementation
and, furthermore, studies involving LC and carbohydrate (CHO) supplementation are relatively
modern. Thus far, chronic LC and CHO supplementation (> 4 weeks) has given a promising
insight into enhancing athletic performance by reducing the physiological effects of exercise and
improving recovery. Currently, many studies have been unable to support the use of carnitine
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supplementation to enhance athletic performance, however these conclusions have been drawn
based on small numbers of participants, short duration of supplementation, lack of appropriate
control groups (Higdon, 2002), type of supplementation, or control of diet before exercise
(Abramowicz & Galloway, 2005), so further research is necessary in this area. Therefore, the
purpose of this study was to examine the effect of chronic L-carnitine and carbohydrate feeding
on athletic performance, body composition, and perceived exertion in female endurance athletes.

Limitations:
•

Random assignment of supplement groups (carbohydrate + L-carnitine or L-carnitine)

•

Inability to collect blood samples for analysis

•

Small sample size

•

Not regulating menstrual cycle

•

Spring Break fell in the middle of the study protocol, postponing testing for some of the
participants.

•

Other limitations to this study included possible threats to internal and external validity
including history of gastrointestinal or metabolic disorders, mortality, maturation, testing
and instrumentation, as well as the reactive or interaction effect of testing.

Delimitations:
Participants for this study consisted of recreationally active females, ages 19-22 years, who were
participating in at least 150 minutes of endurance exercise a week. Participants were familiar
with the addition of CHO supplements in their dietary regimen and were not taking any
performance enhancing drugs or any medications that may affect body composition or appetite.
Participants ceased any additional supplementation regimen for the duration of the study and
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maintained their training regimen and diet. Participants also must have been taking oral
contraceptives for at least six months prior to the first trial.

Assumptions:
1. Participants will return for all required exercise protocols.
2. Participants will take their required dosages of the supplement they are given.
3. Participants will take their required supplements at the correct time and frequency
throughout the study.
4. Participants will not be taking any performance enhancing drugs at the time of the study
5. Participants will continue with their current diet and training regimen throughout the
duration of the study
6. The Bod Pod® is a reliable and valid measure of body composition
7. The ParvoMedics TrueOne® 2400 proves to be an accurate and reliable device for the
measurement of gas exchange variables
Operational Definitions:
1. Exhaustion: A state of extreme physical or mental fatigue
2. Carnitine: An amino acid derived from the amino acids, lysine and methionine. Carnitine
plays a crucial role in the transport of fatty acids into the mitochondria.
3. VO2peak: Also known as maximal oxygen uptake; refers to the maximum amount of
oxygen that an individual can utilize during intense or maximal exercise. VO2max is one of
many factors that can help predict an athlete's ability to perform sustained exercise.

15

CHAPTER 2
LITERATURE REVIEW
Carnitine in the Human Body
L-Carnitine is just one of the many critical components involved in the metabolic process
of beta-oxidation. The most widely researched aspect, and primary function, of this amino acidlike substance is its role in the transportation of long-chain fatty acids (LCFAs) across the inner
mitochondrial membrane (Karlic & Lohninger, 2004) for use as fuel by the body. With the main
sites for carnitine storage being cardiac and skeletal muscle (Higdon, 2002), carnitine also acts as
a buffer for excess acetyl-CoA in the muscle that accumulates during exercise (Broad, Maughan
& Galloway, 2005). This buffering mechanism is thought to relieve the inhibition of the
pyruvate dehydrogenase enzyme complex (PDC), which in turn increases glycolytic flux during
exercise (Broad et al., 2005). The main sites for carnitine synthesis include the liver and kidney,
where carnitine can then be transported to other tissues in the body.
Two main enzymes - carnitine palmitoyltransferase I (CPT I) and carnitine
palmitoyltransferase II (CPT II) - make up the carnitine palmitoyltransferase system that is
involved in initiating the transport of LCFAs into the mitochondria (Carnitine Shuttle). In order
for L-carnitine to enter the mitochondrial matrix, it must first be in the form of an ester,
acylcarnitine (Higdon, 2002). CPT I, the rate limiting step in fatty acid oxidation, will then
enable the transfer of the long-chain fatty acids into the cytosol from coenzyme-A (CoA) to Lcarnitine (Higdon, 2002). Once the carnitine is in the matrix, CPT II exchanges CoA for carnitine
to produce fatty-acid CoA, which is then ready to enter fatty oxidation once more to produce
energy, and the free carnitine is released back into the system to repeat the process (Carnitine
shuttle).
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Current studies have produced conflicting results as to whether endurance athletes need
carnitine supplementation. For example, Broad and colleagues (2006) examined the dietary
carnitine intake and carnitine status of endurance-trained males. Researchers recruited 14 nonvegetarian endurance-trained males (ages 18-50 years), all of which completed a seven-day
weighed food record and exercise record prior to the study to determine habitual carnitine intake.
Resting blood samples and urine analyses were used to determine plasma carnitine
concentrations and carnitine excretion in the urine. Researchers found that there were no
correlations between dietary carnitine intake and 1) plasma carnitine concentrations (r = 0.13, p
= 0.68) 2) free carnitine concentrations (0.36, p = 0.23) 3) acyl carnitine concentrations (−0.21, p
= 0.50) or 4) urinary carnitine excretion (total − 0.05, p = 0.87; free 0.07, p = 0.81; acyl −0.16, p
= 0.58). The dietary records of the endurance athletes, along with the results of the study,
conclude that the carnitine levels of the subjects were comparable to normal adult levels and no
dietary insufficiencies were present. Furthermore, no correlation could be noted between dietary
carnitine intake, dietary macro- or micronutrients, and plasma carnitine or urinary carnitine
excretion, indicating the subjects were not at risk for a carnitine deficiency.
Carnitine Metabolism during Exercise
In a fed state, the liver is both an organ of glucose uptake and fat oxidation, the latter
converting glucose to LCFAs, which can then be either stored in the liver or transported to other
tissues (Foster, 2006). However, in a fasted state, these metabolic pathways are essentially
reversed. In a fasted state, the glucose production and fatty acid synthesis in the liver cease, and
fatty acid oxidation begins to take form. This mechanism is one way of providing a defense
against muscle protein catabolism (Foster, 2006).
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Muscle fuel selection is an important factor to consider when it comes to exercise and
carnitine supplementation. Two major substrates available for energy during exercise include fat
and carbohydrates. Under high-intensity, submaximal conditions (> 70% VO2max), the body will
utilize mainly muscle glycogen stores for fuel; however, these stores are relatively small
compared to fat stores (Wall et al., 2013). Studies suggest that exercise at lower intensities (5570% VO2max) will enhance fat oxidation to its maximum potential in endurance-trained athletes
(Achten et al., 2002). Optimizing the use of endogenous fat is an important factor to consider
during endurance exercise as it may spare muscle glycogen stores (Wall et al., 2013).
One study by Hottenrott and colleagues (2012) examined the effects of high-intensity
training vs. endurance training on aerobic power and body composition in 34 recreationally
active men and women. Participants were randomly separated into two groups - 1) weekend
group (WE), who performed two sessions of continuous endurance exercise training on the
weekend, and 2) after-work-group (AW), who performed four high-intensity training sessions
and an additional endurance run during the week, after work. Pre-and post-tests included heart
rate monitoring, body composition (total body fat, total muscle mass, visceral fat), and a fitness
assessment for cardiovascular health (VOpeak). For the 12-week intervention, the WE group
performed 2 h 30 min of continuous endurance running, and AW performed four 30 min sessions
of high intensity training and an additional 30 min endurance run. After the 12-week
intervention, subjects then competed in a half marathon. Results of the study found significant
decreases in both heart rate and body mass in both groups (WE and AW), however the AW
group did not produce significant losses in fat free mass (p = 0.27) or total body mass, but there
were significant decreases in total body mass, visceral fat (6.5%), and fat free mass in the WE
group. Furthermore, both groups (AW and WE) significantly increased aerobic power (p = 0.01)
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after the intervention, however, differences between groups were not observed. Overall, all
subjects completed the half marathon after the 12-week intervention. This study suggests that
both high-intensity and endurance exercise have the ability to improve aerobic capacity as well
as body composition in recreationally trained men and women.
In addition, exercise modality plays an important role in ventilatory patterns. Generally,
the metabolic demands of exercise depend highly on the mode, as well as the amount of muscle
mass recruited to perform the action (Tanner, Joseph, & Stager, 2014). To date, research
examining ventilatory strategies used during cycle ergometry and treadmill running are scarce. In
a study by Tanner and colleagues (2014), twenty-two healthy, trained men (age 23.6  5.7 years)
were recruited to perform two maximal exercise tests in different modes, running and cycling.
Participants were actively involved in running, cycling, or both, and were free of any
cardiovascular or pulmonary disorders. On two separate testing occasions, participants reported
to the lab 4 hours post-prandial, with two days in between each testing session. Each session
consisted of a continuous, incremental exercise bout of running on a treadmill or cycling on an
ergometer to determine maximal aerobic capacity.
Furthermore, Smith and colleagues (2008) examined the effects of glycine propionyl-Lcarnitine on aerobic and anaerobic performance in 43 untrained men and women (ages 18-44).
Participants performed a graded exercise test (GXT) on a motorized treadmill where expired
gases were collected and VO2peak and anaerobic threshold were determined. Researchers also
monitored blood pressure, heart rate, respiratory-exchange ratio (RER), and perceived exertion
(Borg Scale) during the GXT. Anaerobic testing consisted of participants performing a 30-s
cycle sprint test on a stationary cycle ergometer attached to a computer. During testing, peak and
mean power relative to lean body mass were recorded as well as fatigue rate, and total work
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relative to lean body mass. All participants performed the same tests but on different days.
Following the pre-intervention tests - in a randomized, double blind manner - participants were
assigned to one of three conditions: Placebo (1 g cellulose), GPLC-1 (348 mg glycine + PLC at 1
g/day), or GPLC-3 (1,044 mg glycine + PLC at 3 g/day). Participants ingested three capsules two
times per day for 8 weeks, then completed an identical post-intervention testing protocol. No
significant differences (P > 0.05) were identified between or within the three groups for free,
total, or acyl carnitine concentrations, or any of the performance variables. These findings
suggest that GPLC supplementation has little, if any, effect on improving aerobic or anaerobic
performance in untrained men and women more than aerobic exercise alone.
During physical exercise, the ratio of carnitine pools in the body is constantly shifting
between various body compartments, due mainly to the esterification of the free carnitine within
the muscle pool with various acyl groups (Swart, Rossouw, Loots, & Kruger, 1997). Research
suggests that endurance exercise may reduce these carnitine pools in the skeletal muscle and a
carnitine deficiency may ensue - carnitine supplementation attenuating this process (Swart et al.,
1997). For example, Swart and colleagues (1997) examined the effect of L-carnitine
supplementation on plasma carnitine levels and various performance parameters of seven male
marathon athletes (age 27 ± 3 years). Each participant served as their own control, completing
two progressive treadmill tests to exhaustion (0° gradient) separated by six weeks. Heart rate,
oxygen consumption, and RER were measured during the test, and blood samples were drawn
afterwards to determine the total carnitine (TC), free carnitine (FC), and average carnitine (AC)
levels in the blood. Significant increases were found in the mean levels of TC and FC
concentrations (p < 0.05) after L-carnitine supplementation and researchers saw a 5.68% average
increase in peak treadmill running speed. Furthermore, subjects were able to maintain a higher
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peak running speed, at a lower rate of O2 consumption after the carnitine supplementation, and
RER significantly decreased as well. Further research is needed but these findings support
carnitine supplementation and its ability to enhance overall running performance and aerobic
capacity.
Carnitine and Carbohydrate (CHO) Supplementation
The American College of Sports Medicine (ACSM) recognizes carbohydrate
supplementation as an important aspect of an athlete’s training and nutrition program. ACSM
guidelines recommend that endurance athletes consume 2-3 grams of CHO/kg of body weight
three to four hours prior to exercise, and fuel every 40-60 minutes. Furthermore, the effect of
CHO on performance depends greatly on the duration and intensity of the event, as well as the
training status of the athlete, the type of CHO, and the mode of exercise (Stellingwerff & Cox,
2014). There are various mechanisms that exist to explain the role of CHO and preventing
fatigue, one being an oral stimulation of the central nervous system (CNS) (Stellingwerff & Cox,
2014). For example, CHO can attenuate the effects of fatigue via a direct energy contribution
from CHO oxidation during longer endurance events, as muscle glycogen stores became
depleted more quickly (Stellingwerff & Cox, 2014). Furthermore, research has shown that CHO
supplements have provided a higher benefit to athletes compared to ingesting water alone
(Jeukendrup, 2010).
Smith and colleagues (2010) examined glucose ingestion (15, 30, and 60 g/h) on
endurance performance and fuel selection in 12 recreational healthy male cyclists. Peak VO2 and
onset of blood lactate accumulation (OBLA) were assessed before testing began. Subjects
completed a 2-h cycling exercise at 95% OBLA followed by a simulated 20-km time trial.
Subjects completed four exercise trials - ingesting 2,000 mL of one of four beverages during
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each 2-h ride - each separated by at least seven days. Researchers found that compared to
placebo, significant increases were seen in the time trial mean power output by 7.4%, 8.3%, and
10.7% for 15, 30, and 60 g/h, respectively.
A similar example demonstrating the positive effects of CHO on endurance performance
was in another study by Smith and colleagues (2013) where the dose-response relationship of
CHO and performance was observed. Fifty-one recreationally trained, healthy male cyclists or
triathletes (age 28.4 ± 6.7 years) were recruited for this study. Preliminary testing was used to
determine VO2peak and onset of blood lactate accumulation (OBLA). Subjects performed an
incremental cycling protocol consisting of a 2-h constant load ride at 95% OBLA, immediately
followed by a 20-km time trial on their own bicycles stationed to a bicycle trainer. During four
randomized trials, with 7 days in between each trial, subjects consumed 2,000 mL of 1 of 13
beverages (ranging from 0% - 12% CHO) and electrolytes. Beverages were consumed every 15
minutes in 250-mL portions. Results of the study were able to show that cycling at a VO2peak of
~70%, along with the ingestion of a CHO beverage, significantly improved cycling performance
compared to placebo during a 20-km cycling time trial. Furthermore, improvements in
performance of 1.0%, 2.0%, 3.0%, 4.0%, and 4.7% were seen at 9, 19, 31, 48, and 78 g/h
respectively, with 78 g/h eliciting the greatest response, as performance enhancement diminished
at levels > 78 g/h. In conclusion, this study was able to demonstrate that CHO supplementation
during prolonged exercise durations appear to enhance athletic performance in a curvilinear
dose-response manner.
More recently, researchers have begun to look at the effects of carnitine on glucose
tolerance and insulin sensitivity. Researchers believe that the mechanisms in which carnitine acts
on glucose metabolism requires the action of various contributing factors - 1) enhancement of
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mitochondrial oxidation of long-chain acyl-CoAs 2) modulating the activity of the pyruvate
dehydrogenase complex (PDHC) and the intramitochondrial acetyl-CoA/CoA ratio and 3)
altering the expression of glycolytic and gluconeogenic enzymes to name a few (Ringseis,
Keller, & Eder, 2012). Current research supports the notion that an accumulation of long-chain
acyl-CoAs, as well as other fatty acid metabolites, impairs insulin signaling, therefore,
contributing to the increased insulin resistance in the skeletal muscle and heart (Ringseis et al.,
2012).
As previously mentioned, Wall and colleagues (2011) completed a study that examined
the effects of oral L-carnitine and carbohydrate ingestion on muscle carnitine concentrations and
fuel metabolism during endurance exercise. Researchers were able to demonstrate that muscle
carnitine concentrations could be increased (~15%) in the presence of high serum insulin levels
as well as hypercarnitinaemia (550-600 μmol). On three different occasions over a 24-week
period, participants underwent a 90-minute cycling protocol at various intensities (50% and 80%
of VO2max) to determine whether or not carnitine supplementation, in combination with
carbohydrates, had any effect on body composition, carnitine concentrations in the muscle, or
fuel metabolism. The results of the study revealed no body mass changes in the carnitine group
over the 24-week period. However, when compared to the control group, plasma total carnitine
(TC) concentrations increased in the carnitine group from 12 to 24 weeks, and perceived exertion
was also significantly lower in the carnitine group (p < 0.05) compared to baseline and control (p
< 0.05) after 24 weeks.
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Short-term vs. Chronic Carnitine Supplementation
Currently, few studies can propose a standard period of time that would indicate an ideal
protocol for carnitine supplementation and thus far, the daily requirement of exogenous carnitine
supplementation is unknown (Broad, Bolger, & Galloway, 2006). For example, Orer and
colleagues (2014) examined the effect of two different doses of acute carnitine supplementation
on endurance performance in athletes. Twenty-six healthy trained males (ages 17-19 years) were
recruited for the study. Using a double-blind protocol, each participant was instructed to
consume either 3g (LK-3) or 4g (LK-4) of L-carnitine mixed with fruit juice 1 hour before
measurements were taken. The subjects then completed a progressive treadmill test to
exhaustion, where heart rate was observed during the test, and blood samples were taken
afterwards to measure blood lactate concentrations. One week after the completion of the test,
the athletes returned to the testing site where they underwent the same procedure, however, this
time they were given placebo fluids (P-3) and (P-4). When comparing both sets of groups (LK-3
and P-3, and LK-4 and P-4) significant differences could be noted. A significant difference was
found regarding heart rate and lactate (La) concentrations between the LK-4 and P-4 groups (p ≤
0.05) whereas heart rate and La dropped between running speeds of 8 and 16 km/h. Furthermore,
significant decreases could be noted in the running speeds in both supplemented groups
compared with placebos (p ≤ 0.05).
In addition, Arazi and Mehrtash (2017) examined the effect of acute carnitine feeding on
plasma glucose and lactate concentration, as well as aerobic and anaerobic capacity in elite male
artistic gymnasts. Eighteen gymnasts were recruited for the study and, using a double-blind,
placebo-controlled randomized protocol, subjects were divided into two groups: supplementation
or placebo. Subjects were instructed to perform both an aerobic (20 m shuttle run) and anaerobic
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running-based sprint (RAST) test. 90 minutes prior to the test, subjects in the supplementation
group consumed 3 g of L-carnitine or placebo (maltodextrin) with 200 ml of water. Researchers
collected blood samples 5 minutes before and 4 minutes after the performance trials to assess
lactate and glucose. Results of this study found that, compared to the placebo group, lactate
concentrations in the supplementation group were significantly lower (p  0.05) after the aerobic
(140.4 ± 15.5 mg/dl) and anaerobic (147.8 ±12.8 mg/ dl) exercise tests.
Another example of acute carnitine feeding was in a study done by Parandak and
colleagues (2015) where the effects of acute carnitine ingestion on exercise-induced oxidative
stress and muscle damage were examined. Participants for the study consisted of twenty-one
healthy, active men. Preliminary testing included a VO2max test using the Balke 15-min run test
on a standardized track where participants were encouraged to give maximum effort. In a
randomized, double blind, placebo-controlled manner, participants were assigned to one of two
groups - carnitine (C) or placebo (P) - based on their VO2max. For fourteen days, participants
consumed a daily dose of either 2 capsules containing 2,000 mg L-carnitine or the placebo (2
capsules containing 2,000 mg lactose). Following the 14-day period, the same VO2max test was
administered to the participants under the same conditions. Results of the study revealed no
changes in body composition over the two-week period, however, there were significant
increases in markers of muscle damage (i.e., lactate dehydrogenase activity (p < 0.05), creatine
kinase activity (p > 0.05), and total antioxidant activity (p < 0.05)) immediately after, as well as
2 and 24 hours post exercise in both groups. In addition, there was no significant difference
between running records for the two groups (P group: 73±8.2 vs C group: 71±6.8 min), however,
this may be due to the subjects being placed in groups possessing similar VO2max values. Overall,
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this study was able to demonstrate that acute L-carnitine supplementation may help to alleviate
some of the side effects of short bouts of exercise, but more research is needed.
Likewise, a study by Abramowicz and Galloway (2005) compared the effects of acute vs.
chronic L-carnitine L-tartrate (LCLT) supplementation on metabolic responses to steady state
exercise in males and females. Twelve active, healthy subjects volunteered for the study: six
males (age 25 ± 6 years) and six females (age 30 ± 5 years). Subjects were randomly divided, in
a double-blind crossover design, into 3 periods: placebo (14 days of 3 g glucose/day), acute
supplementation (13 days of 3 g glucose/day, plus 1 day of 3 g LCLT), or chronic
supplementation (14 days of 3 g/day LCLT). Over a period of seven weeks, subjects reported to
the lab on a total of six occasions where they underwent various testing. The first visit consisted
of a VO2max test using an incremental cycle ergometer; the second and third visits were used as
familiarization trials and to determine correct workload. During the final three trials, subjects
were asked to cycle for 60 minutes at 60% of their VO2max. Blood samples were collected
throughout the exercise protocol to determine blood lactate and plasma glycerol concentrations,
and perceived exertion (6-20 Borg scale), respiratory exchange ratio (RER), and heart rate were
monitored as well. The results of the study show that, over the course of the 60-minute exercise,
RER decreased significantly in both genders (p < 0.01). In male subjects, a higher RER was
observed in the chronic ingestion trial compared to placebo (p = 0.04), with no difference
between placebo and acute trials (p = 0.78). On the other hand, no significant differences were
seen between groups in the female population in either the acute (p = 0.07) or chronic (p = 0.06)
ingestion trials. Overall, the increased RER in the male population indicated an increased
reliance on CHO metabolism, with a decreased reliance on fat metabolism, throughout the 60minute exercise protocol for both genders. The current study does not support the effect of a

26

single dose (2-weeks) of L-carnitine L-Tartrate, in combination with CHO ingestion, on
promoting fat oxidation during exercise, however, there is an enhanced rate of CHO oxidation.
As previously mentioned, recent research has reported that chronic ingestion of Lcarnitine and CHO has been shown to prolong exercise endurance as well as aid in the recovery
of muscles post-exercise. For example, Wall et al. (2011) conducted a study on moderately
trained male athletes (age 25.9 ± 2.1 years) to demonstrate that muscle carnitine concentrations
could be increased in association with elevated serum insulin levels ( >50 mU 1-1) and
hypercarnitinemia (550–600 μmol-1). The results of the study showed that muscle carnitine
content was increased by 21% via dietary carnitine supplementation. Additionally, the
researchers could demonstrate that carnitine had an ergogenic effect on the subjects, shown by an
increased work output of 11% from basal measurements. Findings such as these reveal that
carnitine feeding may have certain implications for athletic performance and suggest that muscle
carnitine concentrations can be increased in individuals without deficiencies (Sahlin, 2011).
Research is currently lacking on whether carnitine supplementation can enhance fat
oxidation in healthy humans; however, some researchers believe that carnitine may have
additional benefits in terms of exercise recovery. To date, few studies have been able to
determine a specific dose response for LC supplementation. For example, Spiering and
colleagues (2007) examined the responses of criterion variables to different supplemental doses
of L-carnitine L-Tartrate (LCLT). The study recruited eight healthy male weightlifters (ages 22 ±
3 years) with a year or more of squatting experience. Subjects consumed either 0 g, 1 g, or 2 g of
LCLT at breakfast and lunch for 3 weeks followed by a subsequent squat exercise test. Handgrip
was used to determine maximal strength of the arm musculature as well as blood draws to
determine the appropriate washout period for carnitine concentrations to return to normal.
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Perceived muscle soreness was also assessed at 24, 48, and 72 hours post resistance exercise
(RE) test. Results showed that carnitine concentrations increased with the carnitine doses of 1 g
and 2 g but a significant decrease in muscle soreness was noted in the 2 g dose compared to 1 g
and the 1 g dose compared to 0 g. In conclusion, LCLT supplementation favorably affects
markers of muscle damage and recovery after a bout of resistance exercise and even doses as
little as 1 g per day can supply many of the same benefits associated with 2 g per day of LCLT.
L-carnitine and Fatigue
Although more research is necessary, some studies suggest that carnitine supplementation
may attenuate the effects of fatigue by providing a protective effect on the blood platelets in the
body that play a role in wound healing (Orer & Guzel, 2014). Carnitine is thought to play an
important role in shortening the recovery process and attenuating the damage to the muscles
caused during strenuous exercise (Orer & Guzel, 2014). For example, Cruciani and colleagues
(2015) examined the effects of carnitine supplements on patients with HIV/AIDS in a
randomized, double blind, placebo-controlled study. Thirty-five adults with advanced HIV/AIDS
and moderate to severe fatigue were recruited for this study. Participants were randomly assigned
to one of two groups - 3 g oral carnitine (increasing from 0.5 mg daily to 1.5 g twice daily by day
7) or placebo for 2 weeks. The primary outcomes that were measured included the physical,
emotional, social and functional wellbeing of the patients, performance status, mood, serum
carnitine level, serum lactate level, CD4 count, and more importantly, Brief Fatigue Inventory.
Results of the study concluded that carnitine supplementation did not reduce fatigue in any of the
35 subjects. Likewise, carnitine supplementation did not have any effect on behavioral outcomes.
On the other hand, plasma lactate concentrations fell in the carnitine group compared to the
placebo group and plasma total and free carnitine levels increased. This study was unable to
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support the use of carnitine supplementation to reduce feelings of fatigue in advanced HIV/AIDS
patients with moderate to severe fatigue. Although the results of this study were inconclusive,
future studies may benefit from increasing the dose/duration of the carnitine supplementation in
hopes to produce significant findings.
One study done by Yu and colleagues (2011) examined the effects of a single dose of Lcarnitine on the antioxidant capacity in healthy men and women (mean age 27.7 ± 4.7 years).
Subjects consumed 2.0 g L-carnitine in 200 mL warm water, where venous blood samples were
then taken at various time points between 0 and 24 hours after administration to determine
plasma carnitine concentrations. For this study, researchers measured plasma antioxidant status
in all subjects via the enzymes superoxide dismutase (SOD), glutathione peroxidase (GSH-Px),
and catalase and total antioxidative capacity (T-AOC) activity. A gradual increase in SOD
concentration, as well as GSH-Px, and catalase T-AOC from 0 h to 3.5 h, whereas levels peaked
at 3.5 h, and gradually returned to 0 h at the 24 h point. Overall, the increase in activity of these
antioxidant enzymes suggests that a single dose of L-carnitine in healthy human subjects may be
useful in treating certain cardiovascular and other chronic diseases that are associated with high
levels of oxidative stress.
Female Menstrual Cycle and Performance
As females become more involved in amateur and professional sports, being familiar
with how the menstruation cycle may affect performance becomes especially important.
Researchers became more interested in examining the effects of the female menstrual cycle on
athletic performance (Tsampoukos, Peckham, James, & Nevill, 2010) and whether or not the
menstrual cycle phase could possibly hinder athletic ability. For instance, Tsampoukos and
colleagues (2010) examined the effects of the menstrual cycle phase (MCP) on sprinting and the
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recovery response to exercise. Fourteen highly trained female sport science students (mean age
20.1 ± 0.3 years) volunteered for the study. Subjects were eumenorrheic, were studied prior to
ovulation, and refrained from taking any oral contraceptives for at least 4 months prior to the
study. Two important hormones associated with the menstrual cycle – 17 B-estradiol and
progesterone, were noted for this study. Once preliminary trials were done, subjects completed a
performance test on three different occasions (follicular phase, just prior to ovulation, luteal
phase) consisting of a 30-sec sprint with a 2-min recovery period on a non-motorized treadmill.
Peak power output (PPO), mean power output (MPO), fatigue index for power (FIPO), peak
speed (PS), mean speed (MS) and fatigue index for speed (FISP) were measured during the
performance test and blood samples were analyzed at different time points during and after the
test (rest, post-warm-up, immediately after the first sprint, immediately after the second sprint
and at 5, 10, 15, 20 and 30 min during the recovery from the second sprint). Results of the trials
determined that, for the 8 subjects included in the study, no significant changes in body mass
could be seen (p > 0.05). Furthermore, no significant changes in any of the performance
variables were seen, as they were unaffected by MCP (p >0.05). The main findings of this study
conclude that athletic performances on a 30-second sprint test were not influenced by the
hormonal fluctuations of MCP or by 17 B-estradiol and progesterone, which fluctuate during the
menstrual cycle. This research supports the notion that MCP likely does not affect performance
in the female athlete under eumenorrheic conditions.
Another point to consider when females are readily involved in endurance training is the
use of oral contraceptives. Plasma ethanol estradiol, a hormone found in many oral
contraceptives, inhibits the production of the hormone 17 B-estradiol, and appears six times
higher in individuals taking oral contraceptives than those that do not (Joyce, Sabapathy, Bulmer,
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& Minahan, 2013). A study by Joyce and colleagues (2013) set out to determine the effect of
long-term use of oral contraceptives on the endurance performance of 16 recreationally active
women. The participants were separated into two groups: oral contraceptive (OC) and those who
were not using oral contraceptives (CON). Once separated, baseline blood samples were taken to
assess 17 B-estradiol and progesterone levels. Then, participants completed an incremental
exercise test to exhaustion on an electronically braked cycle ergometer to determine peak VO2
(VO2peak) and anaerobic threshold (AT). The test consisted of 3 minutes of cycling at 30 W,
followed by power increments at 10 W for 30 seconds until volitional exhaustion. Participants
also completed four submaximal exercise tests (the first two as practice tests) that involved
cycling at a cadence of 70 RPM for three work stages. During the tests, heart rate (HR), ratings
of perceived exertion (RPE), pulmonary gas exchange, blood lactate concentration (La), and time
to exhaustion were measured. Overall, significant differences were observed in VO2peak (P =
0.03) and VO2 at AT (P = 0.02) in the CON group when compared to the OC group. However,
HR, BP, and La concentrations were not significantly different between the groups. The results
of the current study propose that long-term use of oral contraceptives negatively effect VO2peak
and VO2 at AT, but have no effect on athletic performance in recreationally trained female
endurance runners.
The menstrual cycle can be divided into four phases: the menstrual phase, the follicular
phase, the ovulation phase, and the luteal phase. For the most part, studies suggest that the
menstrual cycle does not affect athletic performance in females; however, a study by Ubukata
and Matsumura (2015) suggests that the menstrual cycle can be affected during these different
phases. Ubukata and Matsumura (2015) suggest that injuries occur more often in females during
the menstrual phase than the rest of the menstrual cycle, since estrogen and progesterone levels
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are low during this time. For this study, researchers examined the relationship between the
phases of the menstrual cycle and the transverse abdominis muscle (TrA). Fifteen healthy, young
females (age 18.6 ± 0.9 years) with regular menstrual cycles were chosen for this study. The
thickness of the TrA was measured a total of three times, using an ultrasound imaging apparatus
under both resting and contractile conditions. Likewise, both the left and the right side were
measured and the average thickness of the muscle on both sides used for analysis. The results of
the study showed that, regardless of menstrual cycle phase, the thickness of the TrA muscle
increased significantly during contraction. Overall, researchers were unable to observe any
significant differences in muscle thickness of the TrA in the menstrual cycle phase; thus, muscle
contraction was not affected during the fluctuation of sex hormones, indicating the TrA does not
depend on the menstrual cycle.
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CHAPTER 3
METHODOLOGY
Participants
Eight, healthy, recreational female endurance runners were recruited for this study.
Volunteers were college students between the ages of 19 and 22 years old. The Institutional
Review Board (IRB) at Georgia Southern University approved this study. The participants were
informed of the possible risks involved with participating in this study and completed written
informed consent. The participant’s demographic information was collected, which included the
number of days per week they were currently running and how long each running session
typically lasted. All participants were also asked to complete a 72-hour dietary recall to assess
average carbohydrate intake, as well as average carnitine intake.

Instrumentation
Participants had their weight and height assessed in the human performance lab at
Georgia Southern University using a calibrated scale and stadiometer during the first week of the
study. Participants also completed a 72-hour dietary recall during the first week before the first
trial to assess average carbohydrate and carnitine intake. Participants were asked to maintain
their current training regimen and diet throughout the duration of the study. During the first trial,
participants completed a body composition assessment using the Bod Pod® and performed a
timed treadmill test to exhaustion. For the BodPod body composition analysis, optimal results
require participants to wear minimal clothing (spandex shorts and/or a sports bra) and a swim
cap. They are then weighed on a calibrated digital scale to the nearest 20 g. Next, the participant
sat in the air displacement plethmysography (ADP) chamber and be asked to breathe normally
while three body measurements will be taken to assess body volume. In addition, thoracic gas
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volume measurements were predicted using gender, age, and height. Measurements taken from
the BodPod include: lung volume (L), body volume (L), body density (kg/L), body fat
percentage, fat weight (kg), and lean weight (kg).
During the first visit, each participant was given oral and written information regarding
the testing procedures. Participants performed a VO2peak test one week before the first trial, and
were asked to complete a second VO2peak test one week after the final trial to verify that no
changes in aerobic capacity had occurred over the course of the study. Expired gases were
analyzed using the ParvoMedics TrueOne® 2400 open circuit spirometry system. This consists
of a room air auto-calibration routine and a two-point gas calibration with a single gas tank
(15.09% O2, 6.01% CO2). The ParvoMedics TrueOne® 2400 has been shown to be an accurate
and reliable device for the measurement of gas exchange variables (Crouter et al., 2006). All
measurements were taken in the human performance lab at Georgia Southern University in the
same session.
Procedures
Food Log Protocol: Prior to the first trial, participants were instructed to complete a 72hour measured dietary recall (one weekend day and two week days). Participants downloaded the
MyFitness Pal app that is available on both iPhone and Android devices. The dietary recall was
analyzed for an estimate of baseline carbohydrate intake, as well as total daily macronutrient
intake. An estimate of carnitine consumption was also determined using a calculation used in
previous research (Rebouche, 1999).
Exercise Protocol: One week before the trial, each participant’s maximal oxygen uptake
(VO2peak) was measured while participants ran on a treadmill to determine baseline
measurements. Upon arrival, height (cm) - measured using a stadiometer, weight (kg) - measured
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using a calibrated scale, and body mass index (kg/m2) was determined. Participants were
instructed to 1) wear comfortable, loose-fitting clothing, 2) refrain from consuming any alcohol,
tobacco, or caffeine for at least 12 hours prior to taking the test, 3) refrain from participating in
any strenuous physical activity the day before, as well as the day of the test, 4) get an adequate
amount of sleep the night before the test (6-8 hours).
Prior to testing, participants were fitted with headgear, a mouthpiece and a nose clip.
Heart rate was monitored continuously throughout the protocol by a Polar® Heart Rate monitor
with a sensor located on the chest. Participants completed a 3-5 minute warm-up at a selfselected speed at a 0° grade. The participant was informed that this self-selected speed should be
similar to a light jog, nothing too taxing on the runner. The speed the participant chose to run at
determined the starting point for their exercise protocol. After the initial warm-up, the test began
and was comprised of 2-minute stages. In each stage, speed was raised by 1.0 mph and after the
third stage, grade increased by 2% per stage. Through the duration of the test, various criteria
was monitored including: VO2, heart rate (HR), respiratory exchange ratio (RER), and rate of
perceived exertion (RPE). RPE (Borg Scale 6-20) was taken at the end of each stage. Criteria for
ending the test included: (1) a plateau in oxygen uptake (2) maximal heart rate was reached (3)
RER > 1.15 (4) volitional exhaustion (the point at which the participant voluntarily stopped the
exercise). The test was discontinued if all test criteria were achieved or when the participant
chose to stop.
One week after the pre-testing, subjects returned for the first trial, performing a
progressive treadmill test (0° gradient) to exhaustion. Participants began by running at 8 km/h
and the running speed increased every three minutes by 2 km/h until 16 km/h was reached or
exhaustion was achieved. Thereafter, the speed increased every two minutes by 1 km/h until
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exhaustion, at which point the test was then terminated. Peak running speed was measured at the
highest running speed (km/h) the athlete could maintain for 60 seconds during the exercise test.
During the duration of the test, heart rate and perceived exertion were monitored and time to
fatigue was also noted.
Supplementation Protocol: Participants were divided into two groups based on similar
VO2peak values and then randomly assigned to one of two treatment groups: LC or LC+CHO.
Subjects were then instructed to consume their treatment two times per day for 42 days - the first
supplement 30 minutes before breakfast, and the second supplement 4 hours later or 20-30
minutes before exercise, per the manufacturer’s directions on the bottle. Volunteers were
requested to record any side effects associated with supplementation over the 8-week protocol.
The composition of the supplements is outlined below.
L-Carnitine (LC) Group: 1 scoop (1.30 g) carnitine powder (Gaspari Nutrition ®
Carnitine Tartrate [as Carnipure™] in the flavor Pineapple) mixed with 200 mL of water
containing 0 g CHO, 0 g protein, 0 g fat; Zero Calories per serving.
L-Carnitine + Carbohydrate (LC + CHO) Group: 1 scoop (1.30g) carnitine powder
(Gaspari Nutrition ® Carnitine Tartrate [as Carnipure™] in the flavor Pineapple) and 10
g NOW! Dextrose Powder mixed with 200 mL water. The supplement will contain 9 g
CHO, 0 g protein, 0 g fat; 35 calories per serving.
Supplements were assembled by the researcher in advance and given to participants on
the day of the first exercise session, and again when they returned for the second exercise
session. Directions for supplement use were given verbally and were also written on the
container that held the supplements.
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Study Time Line
Week 1: An informational meeting was held with the participants, during which, the
experimental procedures of the three sessions were reviewed. The timeline for the experiment
was explained to the participants during this time. Each participant read and sign the informed
consent. The researcher clearly explained to the participants that study participation was
voluntary. During week 1, the researcher took anthropometric (height and weight) measurements
of the participants. The participants were also provided with instructions on how to record the
measured food intake for the dietary recall. Also during week one, participants completed a
VO2peak test to assess maximal oxygen uptake. Subjects were then divided into two groups based
on VO2peak values, and then randomly divided into one of the two treatment groups.
Group 1: L-carnitine
Group 2: L-carnitine + carbohydrate
Week 2-4: Measured food logs were shared with the researcher on the first day of testing
to assess total carbohydrate and carnitine intake. Participants completed a progressive treadmill
test to exhaustion as well as a body composition assessment (Bod Pod). Participants began the
supplementation regimen the day after the first exercise session.
Week 5-6: Participants completed the second session of treadmill testing and body
composition assessments and continue their daily supplementation regimen.
Week 7: Subjects completed the third, and final, session of treadmill testing and body
composition assessments and supplementation ended.
Week 8: Subjects returned for final VO2peak testing.
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Statistical Analysis
Three one-way ANOVAs with repeated measures were conducted to compare the effect
of the treatment (LC or LC + CHO) on the participants’ average time to fatigue, average
body composition, and average RPE. It was assumed that participants would return for all
required exercise protocols; would take their required dosages of the supplement given;
would take their required supplements at the correct time and frequency throughout the day;
participants would not be taking any performance enhancing drugs at the time of the study;
would continue with their current diet and training regimen throughout the duration of the
study; the Bod Pod® is a reliable and valid measure of body composition; and the
ParvoMedics TrueOne® 2400 proves to be an accurate and reliable device for the
measurement of gas exchange variables
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CHAPTER 4
RESULTS
For average time to fatigue, the analysis revealed no significant interactions or main
effects for time and treatment, Wilks’ Lambda = .33, F (2,4) = 4.02, p = .11, 2partial = .668. In
addition, no significant differences were seen between or within subjects for body composition
(%FFM, Wilks’ Lambda = .74, F(2,4) = .72, p = .54, 2partial = .26; FFM, Wilks’ Lambda = .41,
F(2,4) = 2.89, p = .17, 2partial = .59; FM, Wilks’ Lambda = .87, F(2,4) = .31, p = .75, 2partial =
.13 or %FM, Wilks’ Lambda = .76, F(2,4) = .64, p = .57, 2partial = .24) or RPE, Wilks’ Lambda
= .97, F(2,4) = .06, p = .95, 2partial = .03.
Participant Characteristics
Seven female participants completed the study. One subject was removed from the study
after failure to adhere to required criteria for the study. All other participants reported to the
study for all testing sessions. Descriptive statistics are summarized in Table 1.
Participants performed a VO2peak test before experimental testing began. Participants were
then divided into groups based on similar VO2peak values, as this indicates similar levels of
fitness. Participants in both groups were tested before and after the 8-week supplementation and
exercise protocol to assess pre- and post-test values. Table 2 shows the results of the pre- and
post- VO2peak test for both supplement groups.
Participants’ time to fatigue was recorded after each progressive treadmill test. An
ANOVA with repeated measures was used to compare time to fatigue between and within both
supplement groups before and after the 8-week supplementation period. Results of the analysis
revealed no significant interactions or main effects for time and treatment (p = .11), however,
analysis revealed a large effect size (2partial = .668).
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In addition to the progressive treadmill test, participants were required to have body
composition measurements performed using the BodPod body analyzer. Body composition
measurements were performed before each progressive treadmill test and included percent fat
free mass (%FFM), fat free mass (FFM), fat mass (FM), and percent fat mass (%FM). An
ANOVA with repeated measures was used to compare body composition between and within
both supplement groups before and after the 8-week supplementation period. The ANOVA
revealed no significant differences between subjects for body composition (%FFM p = .54; FFM
p = .17; FM p = .75; or %FM p = .57) but did show a large effect size for all components of the
body composition assessment (2partial = .26, 2partial = .59, 2partial = .13, 2partial = .24,
respectively). Tables 4, 5, 6, and 7 display the data collected from each assessment.
Furthermore, rating of perceived exertion was recorded during each progressive treadmill
test. An ANOVA with repeated measures was used to compare ratings of perceived exertion
between and within both supplement groups before and after the 8-week supplementation
protocol. Table 8 shows the results of the rating of perceived exertion for both supplement
groups for each exercise protocol. Results of the analysis revealed no significant differences
between or within subjects for both groups (p = .95).
In order to get an idea of the average number of carbohydrates and carnitine consumed by
each participant, average carbohydrate and carnitine intake were assessed using a 72-hour dietary
recall. Details of the recall are outlined in Table 9 and 10.
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Table 1
Summary of information of subject age, weight, and other contributing factors (n = 7)
Variable

Mean  SD

20.28  1.25
140.85  19.33
171.42  7.63
4.78  0.80
37.92  13.72

Age (years)
Weight (kg)
Height (cm)
Days run/week
Time run/day (min)
Average calories/day (kcal)
Average carnitine intake/day (mg)
Average carbohydrate intake/day (g)

1675.85  474.61
13.42  10.69
181.44  56.94

Table 2
Average VO2max values for both treatment groups before and after supplementation(n=7)
Mean  SD

Variable

38.26  1.05
45.83  2.20
41.80  1.76
45.50  0.85

LC (Pre)
LC+CHO (Pre)
LC (Post)
LC+CHO (Post)

Table 3
Average Time to Fatigue for Trial 1, 2, and 3 for both supplement groups(n=7)
Time to Fatigue
Session 1 (min)
Time to Fatigue
Session 2 (min)
Time to Fatigue
Session 3 (min)

Treatment
LC
LC+CHO
Total
LC
LC+CHO
Total
LC
LC+CHO
Total

Mean
7:49
11:31
9:24
7:54
10:42
9:06
8:19
11:31
9:27

Std. Deviation
2:02
0:51
2:29
1:18
0:48
1:48
1:20
0:45
1:55

N
4
3
7
4
3
7
4
3
7
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Table 4
Average Percent Fat Free Mass for Trial 1, 2, and 3 for both supplement groups (n=7)
Percent Fat Free
Mass Session 1
Percent Fat Free
Mass Session 2
Percent Fat Free
Mass Session 3

Treatment
LC
LC+CHO
Total
LC
LC+CHO
Total
LC
LC+CHO
Total

Mean
74.83
80.40
77.21
75.38
81.47
77.99
75.38
81.17
77.43

Std. Deviation
5.95
6.19
6.27
6.78
6.55
6.92
5.26
7.26
6.16

N
4
3
7
4
3
7
4
3
7

Table 5
Average Fat Free Mass for Trial 1, 2, and 3 for both supplement group (n=7)
Fat Free Mass
Session 1 (kg)
Fat Free Mass
Session 2 (kg)
Fat Free Mass
Session 3 (kg)

Treatment
LC
LC+CHO
Total
LC
LC+CHO
Total
LC
LC+CHO
Total

Mean
55.90
54.90
55.47
57.33
55.57
56.57
44.98
54.83
49.20

Std. Deviation
26.06
4.65
18.63
23.60
3.57
16.84
4.12
3.65
6.38

N
4
3
7
4
3
7
4
3
7

Table 6
Average Fat Mass for Trial 1, 2, and 3 for both supplement groups (n=7)
Fat Mass Session 1
(kg)
Fat Mass Session 2
(kg)
Fat Mass Session 3
(kg)

Treatment
LC
LC+CHO
Total
LC
LC+CHO
Total
LC
LC+CHO
Total

Mean
14.98
13.83
14.49
18.40
13.13
16.14
14.80
14.10
14.50

Std. Deviation
4.75
6.48
5.07
7.12
6.81
6.98
4.27
7.41
5.25

N
4
3
7
4
3
7
4
3
7
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Table 7
Average Percent Fat Mass for Trial 1, 2, and 3 for both supplement groups (n=7)
Percent Fat Mass
Session 1 (%)
Percent Fat Mass
Session 2 (%)
Percent Fat Mass
Session 3 (%)

Treatment
LC
LC+CHO
Total
LC
LC+CHO
Total
LC
LC+CHO
Total

Mean
25.18
19.60
22.79
24.63
18.60
22.04
24.63
19.83
22.57

Std. Deviation
5.95
6.19
6.27
6.78
6.67
6.94
5.26
7.26
6.16

N
4
3
7
4
3
7
4
3
7

Table 8
Average Rating of Perceived Exertion for Trial 1, 2, and 3 for both supplement groups (n=7)
Rating of Perceived
Exertion Session 1
Rating of Perceived
Exertion Session 2
Rating of Perceived
Exertion Session 3

Treatment
LC
LC+CHO
Total
LC
LC+CHO
Total
LC
LC+CHO
Total

Mean
15.00
18.00
16.29
16.25
17.00
16.57
16.50
17.00
16.71

Std. Deviation
1.63
1.73
2.22
1.50
.00
1.13
1.00
.00
0.76

Table 9
Average carbohydrate intake (g) prior to the start of the study (n=7)
Group
Mean  SD
LC
163.72  72.37
LC+CHO
204.86  20.77

Table 10.
Average carnitine intake (mg) prior to the start of the study (n=7)
Group
LC
LC+CHO

Mean  SD
16.50  14.01
9.30  2.08

N
4
3
7
4
3
7
4
3
7
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CHAPTER 5
DISCUSSION
One of the many functions of carnitine is its role in the translocation of long-chain fatty
acids into the mitochondrial matrix for subsequent B-oxidation (Stephens, Constantin-Teodosiu,
& Greenhaff, 2007). Over the last decade, researchers have been investigating the effect of
carnitine supplementation as an ergogenic aid, with the idea that increasing carnitine availability
in the muscle would increase fat oxidation and spare muscle glycogen stores, thus delaying the
onset of fatigue. However, limited research has been able to support the use of carnitine
supplementation to enhance athletic performance, and previous research has shown that carnitine
feeding has no effect on muscle carnitine stores in the body. As previously mentioned, there is
limited research on carnitine supplementation, particularly with carnitine in combination with
carbohydrates. The purpose of this study was to examine the effect of L-carnitine, in
combination with carbohydrates, on body composition and overall athletic performance in
recreational female endurance athletes. The results of this study revealed no significant
interactions or main effects for time and treatment for time to fatigue. In addition, no significant
differences were seen between or within subjects for body composition.
Previous research has shown that L-carnitine supplementation can affect performance and
fatigue in endurance athletes (Karahan et al., 2010; Stephens et al., 2013; Arazi & Mehrtash,
2017). To date, studies investigating the effect of LC supplementation on exercise performance
have used gas-analysis techniques as well as cycle ergometry to evaluate performance variables,
as exercise modality plays a role in ventilatory patterns. A study by Tanner, Duke, and Stager
(2014) examined the effect of different modes of exercise on ventilatory patterns. Data collection
showed that, although no observed differences were seen in ventilation (VE) between running

44

and cycling during the maximal exercise test, different breathing patterns were observed. This
difference in breathing pattern is important to the current study to distinguish the physiological
differences between treadmill running versus biking, as the current study utilized the treadmill in
assessing exercise performance.
Some studies have suggested that athletes are able to withstand higher workloads at lower
levels of oxygen consumption during exercise after a single dose of L-carnitine (Vecchiet, Di
Lisa, & Pieralisi, 1990). The function of carnitine during mitochondrial metabolism may be a
contributing factor to the overall increase in effectiveness of oxygen utilization, as other studies
have seen decreases in respiratory exchange ratio (RER) values during VO2max testing during Lcarnitine supplementation (Wyas, Ganzit, & Reizi, A, 1990). For example, Swart and colleagues
(1997) examined the effect of L-carnitine supplementation on plasma carnitine levels and various
performance parameters of male marathon athletes. After six weeks of L-carnitine
supplementation, the results of the study revealed a 5.68% average increase in treadmill running
speed compared to baseline values, and a decrease in average oxygen consumption and heart
rate. In addition, a decrease in RER values were observed when compared to baseline values,
which indicates an increased reliance on lipid oxidation as a fuel source during aerobic exercise.
One of the aims of the current study was to assess average time to fatigue for each timed
exercise trial and, unlike Swart and colleagues (1997), the current study did not find any
significant differences in those measurements between or within participants. These results could
be due to participants becoming accustomed to performing the exercise protocol or participants
possessing similar levels of fitness in each group. Furthermore, the participants used in the study
by Swart and colleagues (1997) were highly trained, triathlon athletes, whereas the participants
used in the current study were recreational, college-aged endurance runners.
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In addition, Orer and Guzel (2014) examined the effects of two different does of Lcarnitine on the endurance performance of male soccer players, aged 17-19 years. Based on
blood samples obtained from participants, the researchers found differences in running speeds
between groups at different lactate concentrations (2, 2.5, 3, 3.5, and 4 mmol/L-1), whereas
fatigue occurred at a slower rate in both groups after carnitine supplementation compared with
the placebo trial. The current study was unable to collect blood samples for analysis, thus
preventing the examination of lactate concentrations in the blood. The findings from the study by
Orer and Guzel (2014) showed that plasma lactate concentrations decreased after L-carnitine
feeding, suggesting that carnitine may have the potential to help prevent muscle damage caused
by exercise. Similarly, Arazi and Mehrtash (2017) also noticed significantly lower lactate levels
in their supplementation group compared with placebo when examining acute L-carnitine
supplementation on blood lactate, glucose, and anaerobic and aerobic performance in elite male
artistic gymnasts. Workload is closely related to individual differences seen in lactate
concentrations during exercise performance, therefore, future studies should determine which
running speed at which heart rate an athlete reaches their anaerobic threshold.
As mentioned previously, some studies have evaluated rating of perceived exertion (RPE)
to gage perceived effort of participants (Orer & Guzel, 2014; Swart et al., 1997; Wall et al.,
2011) but have found conflicting results (Spiering et al., 2007; Wachter et al., 2002) when using
this as a method of perceived work output. For example, Abramowicz & Galloway (2005)
examined the effect of acute versus chronic L-carnitine supplementation on twelve moderately
trained athletes. Results of the study found no significant differences between trials in rating of
perceived exertion in either males or females. In contrast, Wall et al., 2011 found that after 24
weeks, perceived exertion was lower in the supplement group compared to the control group.
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Similar to the study by Abramowicz & Galloway (2005), the current study protocol
utilized RPE to assess how hard participants believed they were working and participants in the
current study were adapted to endurance-type training, which may have affected how hard they
perceived they were working. This could potentially be the reason as to why the current study
revealed no significant differences in rating of perceived exertion between or within groups for
RPE.
Overall, observing lactate concentrations would have been an ideal way to measure how
much participants adapted to the work they were performing. Experienced runners will exhibit
lower blood lactate levels when compared with untrained runners, making it a good indicator of
training intensity because it does not require the use of heart rate or expired gases (Goodwin,
Harris, Hernandez & Gladden, 2007). Future studies would benefit from collecting blood
samples to better assess lactate concentrations, and ultimately, levels of fatigue.
In addition to reducing levels of and time to fatigue, a popular claim associated with
carnitine is that it aids in fat loss and helps prevent weight gain. Similar to the current study,
previous studies involving L-carnitine supplementation have concluded that L-carnitine has little
effect on body composition (Wutzke & Lorenz (2004); Broad, Maughan, & Galloway (2011)).
For instance, Kruszewski (2011) examined the effect of L-carnitine supplementation, in
combination with body building training, on body composition in beginner body builders using
bioelectrical impedance analysis (BIA). Results of the study concluded that no significant
changes were seen in the fat and water content of the participants after five weeks of L-carnitine
supplementation. Like their study, the current study found no significant differences in body
composition between or within subjects in both groups after eight weeks of L-carnitine
supplementation. Furthermore, unlike the study by Kruszewski (2011), the current study used
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recreationally-trained female endurance runners who met the ACSM guidelines of participating
in at least 150 minutes of physical activity three to five times per week. They were also
accustomed to performing endurance exercise, and therefore their fitness levels were most likely
higher than the participants used in the study by Kruszewski (2011).
The current study used the Bod Pod body analyzer to assess body composition, whereas
previous studies typically utilize BIA or skinfolds for body composition measurements (Broad,
Maughan, & Galloway, 2008). This difference in instrumentation may explain the lack of
significant changes seen in body composition in the current study. In addition, participants may
have violated some of the assumptions of the study by not fasting for a minimum of two hours
before their body composition measurement or performing strenuous exercise prior to testing,
which may have affected the results. Likewise, some participants had to be tested in the Bod Pod
multiple times to get an accurate reading, as the data was not always consistent. Both the current
study and the study by Kruszewski (2011) demonstrated that the claims made by manufacturers
about L-carnitine may not always be true, however, L-carnitine dosing is very individualized and
may be dependent upon the fitness and experience level of the individual (Kruszewski, 2011) to
elicit any effect.
Although previous studies have not supported the use of carnitine as a fat loss
supplement, some more recent studies have shown the potential of L-carnitine supplementation
to prevent increases in fat accumulation (Stephens et al., 2013); Wall et al., 2011). For example,
Stephens and colleagues (2013) examined the effect of twelve weeks of L-carnitine feeding on
energy expenditure and body fat accumulation in recreationally active males. Unlike the current
study, results of their study showed no change in body composition in the LC group before or
after supplementation, whereas the body composition of the control group increased in every
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participant after twelve weeks. In addition, when examining the effects of L-carnitine
supplementation in combination with carbohydrates on muscle carnitine concentrations and fuel
metabolism during endurance exercise, Wall and colleagues (2011) found no changes in body
mass in the carnitine group over a period of 24 weeks. They also noticed a 2.4 kg increase in
body mass after the 12-week period in the control group when compared to baseline. Compared
to the current study, the Wall (2011) study protocol extended a period of 24 weeks, whereas the
current study supplementation period was only 8 weeks. In addition, participants in their study
were male athletes training at least 3-5 times per week, performing triathlon-type exercise
(biking, running, swimming). Previous research with carnitine supplementation suggests that
longer supplementation periods have shown to be more successful in finding significant changes
when examining body composition (Wall and colleagues, 2011; Stephens and colleagues, 2013).
The study by Wall and colleagues (2011) also incorporated roughly 600 additional
calories (80 g CHO) into the diets of their participants, while the current study protocol only
included an additional 70 calories (22 g of carbohydrates). Participants in their study were
informed of the caloric intake and told to account for it in the diet, but the low number of calories
coming from carbohydrates in the current study protocol was most likely too small to elicit any
type of physiological response such as weight gain. Unlike the studies by Wall (2011) and
Stephens (2013), the current study reported overall caloric intake using a 72-hour dietary recall
which isn’t always accurate.
Swart and colleagues (1997) accounted for overall caloric consumption (energy from
calories, carbohydrates, lipids, and protein) throughout the entire duration of their study, whereas
the current study only had participants report average carbohydrate and carnitine intake over a
72-hour period. Determining percentage of calories coming from lipid sources would be an
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important factor to consider in future studies since lipids must be available for carnitine
supplementation to be of any value during endurance exercise. Furthermore, it must be possible
for those lipids to be utilized, which is also achieved through lower-intensity exercise. As
mentioned previously, dietary carnitine is predominately obtained through animal protein
sources and the participant’s diets in the current study, as well as in the study by Swart (1997),
were more carbohydrate heavy, possibly resulting in a lower level of free carnitine in the body
and thus, a slight deficiency.
Future studies may benefit from having participants record daily food logs throughout
the duration of the study to keep track of energy consumed from macronutrients, as this is an
important factor of overall lipid utilization and would be a more accurate way of determining
caloric intake. In addition to reporting overall caloric intake, the current study protocol
instructed participants to maintain their current diet and exercise regimen throughout the study
protocol but societal and psychological factors may have prevented participants from doing so.
For instance, Spring Break fell in the middle of the study protocol and many participants left for
vacation during that time. This made it difficult for the researcher in the current study to make
sure participants were still maintaining their normal routine and taking the supplements
accordingly.
In conclusion, this study found that eight weeks of carnitine supplementation, in
combination with carbohydrates, did not increase work output or decrease feelings of fatigue in
female recreational endurance runners. In addition, eight weeks of carnitine and carbohydrate
supplementation did not have a significant effect on body composition or rating of perceived
exertion. This study attempted to simulate routine diet and exercise conditions for this specific
population (college-aged recreational runners) during the supplementation protocol. Participants
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in this study were college-aged recreational runners, therefore psychological and societal factors
enhanced the possibility of diverging from normal diet and exercise routine, limiting their intake
of the supplement and unknowingly altering body composition.
Furthermore, the current study had a small sample size (n=7), which could have been
attributed to the limited inclusion criteria initially set forth by the researcher. The small sample
size prevented the use of a control group in addition to the two supplement groups. Having a
control group and an experimental group allows the researcher to manipulate one aspect of the
study and allows the researcher to see if the group getting the treatment behaves any differently
from the group not receiving the treatment (Tetyana, 2012). Having a control group is important
if the researcher wants to assess the impact of a certain treatment, thus future studies may benefit
from having this group. Like mentioned previously, future studies would also benefit from
obtaining blood samples from participants to analyze carnitine concentrations in the muscle as
well as blood lactate concentrations after ingestion of the L-carnitine and carbohydrate
supplement and exercise performance.
Currently, many studies have been unable to support the use of carnitine supplementation
to enhance athletic performance; however, these conclusions have been drawn based on small
sample sizes, short duration of supplementation, type of supplementation, and lack of control of
diet before and after supplementation (Abramowicz & Galloway, 2005). Despite the limitations
in this study, the results suggest that consumers should be wary of the claims made by
supplement companies that state L-carnitine helps prevent weight gain and promotes fat loss, as
the data in this study suggest otherwise.
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